DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Lazaar AL, Miller BE, Donald AC. et al; for 205724 Investigators.
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Respir Res 2020;
21 (01) 149
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.